User profiles for Hanna Rennert
Hanna RennertDirector, Molecular Pathology Lab, Weill Cornell Medicine Verified email at med.cornell.edu Cited by 4354 |
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
killed over a million people, including >25,000 in New York City (NYC) alone. The …
killed over a million people, including >25,000 in New York City (NYC) alone. The …
Whole-exome sequencing of metastatic cancer and biomarkers of treatment response
Importance Understanding molecular mechanisms of response and resistance to anticancer
therapies requires prospective patient follow-up and clinical and functional validation of …
therapies requires prospective patient follow-up and clinical and functional validation of …
Genetic risk assessment in carrier testing for spinal muscular atrophy
As evidenced by the complete absence of a functionally critical sequence in exon 7,
approximately 94% of individuals with clinically typical spinal muscular atrophy (SMA) lack both …
approximately 94% of individuals with clinically typical spinal muscular atrophy (SMA) lack both …
[PDF][PDF] Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States
The emergence and spread of SARS-CoV-2 lineage B.1.1.7, first detected in the United
Kingdom, has become a global public health concern because of its increased transmissibility. …
Kingdom, has become a global public health concern because of its increased transmissibility. …
Clinical, pathologic, and molecular features of early-onset colorectal carcinoma
The incidence of colorectal carcinoma has increased among patients< 40 years of age for
unclear reasons. In this study, we describe the clinical, pathologic, and molecular features of …
unclear reasons. In this study, we describe the clinical, pathologic, and molecular features of …
Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma
Immunohistochemical stains are routinely used to detect abnormal DNA mismatch repair (MMR)
protein expression in colorectal carcinomas, particularly when Lynch syndrome is …
protein expression in colorectal carcinomas, particularly when Lynch syndrome is …
Clinical performance of SARS-CoV-2 molecular tests
…, LF Westblade, S Whittier, H Rennert… - Journal of clinical …, 2020 - Am Soc Microbiol
Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer …
We describe Exome Cancer Test v1. 0 (EXaCT-1), the first New York State-Department of
Health-approved whole-exome sequencing (WES)-based test for precision cancer care. EXaCT…
Health-approved whole-exome sequencing (WES)-based test for precision cancer care. EXaCT…
Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline
IZ Ben-Dov, YC Tan, P Morozov, PD Wilson, H Rennert… - PloS one, 2014 - journals.plos.org
Background Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic.
Biomarkers are needed to predict prognosis and guide management. We aimed to profile …
Biomarkers are needed to predict prognosis and guide management. We aimed to profile …
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations
Objective: This paper describes the Precision Medicine Knowledge Base (PMKB; https://pmkb.weill.cornell.edu
), an interactive online application for collaborative editing, maintenance, …
), an interactive online application for collaborative editing, maintenance, …